• S&P 500: 1,340.01
  • Change: -0.88%
$102.41 -1.19 (-1.15%)
2/10/2012 10:18 AM

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

CAPS Rating: 2 out of 5

The Company is a biopharmaceutical company that discovers, develops, and intends to commercialize pharmaceutical products for the treatment of serious medical conditions.

Current Price $102.41 Mkt Cap $9.38B
Open $103.00 P/E Ratio 0.00
Prev. Close $103.60 Div. (Yield) N/A (N/A)
Daily Range $102.00 - $103.84 Volume 115,791
52-Wk Range $34.05 - $105.42 Avg. Daily Vol. 0

Caps

How do you think REGN will perform against the market?

You must Sign in to MSN Caps before you can make a call.

All Players

139 Outperform
35 Underperform
 

All-Star Players

41 Outperform
12 Underperform
 

Wall Street

15 Outperform
1 Underperform
 

Top REGN Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

zzlangerhans (99.32)
Submitted August 05, 2011

I took a chance and dumped out of Regeneron yesterday to preserve my positive score, and I was rewarded by escaping the 8% drop today as the tide went out. Unlike many of the other biotechs getting the pinata treatment this week, Regeneron has an… More

TMFUltraLong (99.99)
Submitted September 09, 2011

Very simply, I don't see Eylea being worth this much. Sure the data has shown its more effective than Avastin, but a $6.6 billion price tag and even in a utopian view maybe 10 times 2012 sales just seems unrealisitc. Arcalyst sales are flat and… More

REGN VS S&P 500 (SPY)

Fools bullish on REGN are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about REGN.

Recs

0
Member Avatar 2trpop (67.96) Submitted: 1/17/2012 9:17:40 AM : Outperform Start Price: $77.77 REGN Score: +28.59

momentum Play

Recs

0
Member Avatar davidm9999 (30.52) Submitted: 1/16/2012 4:10:38 PM : Underperform Start Price: $77.77 REGN Score: -28.59

Just popped, irrationally

Recs

0
Member Avatar R1000 (< 20) Submitted: 1/10/2012 3:48:09 PM : Outperform Start Price: $74.03 REGN Score: +34.50

Ahead of it's competitors in a drug Macular Degeneration which causes blindness in 50+ age group.

Leaderboard

Find the members with the highest scoring picks in REGN.

Score Leader

oneisthelonelies

oneisthelonelies (< 20) Score: +628.19

The Score Leader is the player with the highest score across all their picks in REGN.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
oneisthelonelies < 20 8/6/2007 Outperform 5Y $14.15 +623.75% -2.10% +625.85 0 Comment
DNAdivaSTL 43.31 7/8/2008 Outperform NS $14.30 +616.15% +10.65% +605.50 0 Comment
Grinnell4Eva 60.22 6/6/2008 Outperform 1Y $14.88 +588.24% +1.70% +586.54 0 Comment
stlb1ues 40.21 6/26/2008 Outperform 1Y $14.96 +584.56% +5.98% +578.57 0 Comment
giffman62 < 20 6/6/2008 Outperform NS $15.22 +572.86% -0.95% +573.81 1 Comment
Pmccorm 89.75 6/5/2008 Outperform 3Y $15.28 +570.22% -0.39% +570.62 0 Comment
benes27 69.19 6/5/2008 Outperform 3M $15.28 +570.22% -0.37% +570.60 0 Comment
UncleSmitty 68.81 7/14/2008 Outperform NS $15.24 +571.98% +10.36% +561.62 0 Comment
danbeachler 84.73 9/27/2006 10/30/2006 Outperform 5Y $15.34 +567.60% +6.81% +560.79 2 Comments
kiranmn 38.64 5/27/2009 Outperform 3Y $14.49 +606.76% +48.20% +558.56 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackRWBaird 90.54 1/10/2012 Outperform NS $74.35 +37.74% +3.65% +34.09 0 Comment
TrackJimCramer 78.14 1/10/2012 Outperform 3W $74.44 +37.57% +3.86% +33.72 0 Comment
TrackUltraLong 71.37 11/2/2011 Underperform NS $55.95 +83.04% +8.30% -74.74 1 Comment
TrackZacks 71.06 8/1/2011 Underperform 3M $52.66 +30.17% -9.16% -39.33 9/6/2011 @ $68.55 1 Comment
TrackRBCCapMkts 93.35 7/28/2011 Outperform NS $54.20 +88.95% +2.69% +86.26 0 Comment
TrackNeedham 92.50 5/9/2011 Outperform NS $51.18 +100.10% -0.06% +100.16 0 Comment
TrackMPAdvisors 96.23 4/7/2011 Outperform NS $43.13 +137.44% +0.42% +137.03 0 Comment
TrackRBCCapMkts 93.35 2/24/2011 Outperform NS $36.55 +70.31% +4.11% +66.20 4/29/2011 @ $62.25 0 Comment
TrackBarclaysCap 93.35 10/25/2010 Outperform NS $28.01 +265.62% +12.82% +252.80 0 Comment
TrackBreanMurray 66.85 10/8/2010 Outperform NS $28.02 +265.49% +15.56% +249.93 0 Comment
TrackEdwardOwens 98.65 6/30/2010 Outperform NS $22.32 +358.83% +31.88% +326.94 0 Comment
TrackRothCapital < 20 1/7/2010 Outperform NS $24.90 +103.45% +19.30% +84.16 5/3/2011 @ $50.66 0 Comment
trackthinkequity 90.35 5/5/2009 Outperform NS $15.03 +581.37% +49.63% +531.74 0 Comment
TrackCreditSuiss 92.68 5/1/2009 Outperform NS $14.20 +621.20% +54.98% +566.22 0 Comment
TrackPiperJaff 89.08 3/30/2009 Outperform NS $14.80 +591.96% +69.80% +522.16 0 Comment
TrackZacks 71.06 11/6/2008 Outperform 3M $17.61 +17.55% +15.63% +1.92 9/24/2009 @ $20.70 1 Comment
trackmerriman 70.99 10/24/2008 Outperform NS $16.69 +513.60% +63.43% +450.18 0 Comment
TrackZacks 71.06 1/14/2008 Outperform 3M $24.54 -20.95% -30.06% +9.12 10/20/2008 @ $19.40 1 Comment
TrackEveillard 96.04 12/31/2007 Outperform NS $24.15 -20.54% -10.19% -10.35 3/31/2008 @ $19.19 1 Comment
TrackCarisandCo 88.66 12/3/2007 Outperform NS $22.30 -21.93% -11.16% -10.77 3/13/2008 @ $17.41 0 Comment
TrackCanaccord 88.89 11/2/2007 Outperform NS $21.19 +383.29% -6.42% +389.71 0 Comment
TrackIcahn 68.01 9/30/2007 Outperform NS $17.80 +475.34% -7.91% +483.25 1 Comment
TrackNeedham 92.50 11/8/2006 Outperform NS $23.95 +86.47% -3.54% +90.01 3/31/2011 @ $44.66 0 Comment
TrackCreditSuiss 92.68 11/6/2006 Outperform NS $21.05 -17.77% +1.49% -19.26 6/5/2008 @ $17.31 0 Comment
TrackRBCCapMkts 93.35 10/19/2006 Outperform NS $19.50 -16.87% -22.85% +5.97 10/29/2009 @ $16.21 0 Comment
TrackLehmanBros 88.94 10/19/2006 Outperform NS $19.50 +425.18% +4.40% +420.78 0 Comment
TrackJimCramer 78.14 8/16/2006 Underperform 3W $14.86 +400.94% -0.93% -401.87 1/11/2012 @ $74.44 0 Comment

Featured Broker Partners